Movano Health Applies Advanced AI through Deep Learning To Deliver Improved Accuracy Of Heart Rate In Motion

6/13/24 9:17:27 AM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $MOVE alert in real time by email

Movano Health (Nasdaq: MOVE) announced major advances in the accuracy of its heart rate in motion algorithm following the implementation of deep learning into the processing. The Company recently released an engineering accuracy study directed by Movano Health Founder and CTO Michael Leabman, Enhanced Heart Rate in Motion Accuracy with the Evie Ring Using Advanced Deep Learning Algorithms, which demonstrates the value of deep learning integration into heart rate (HR) algorithms for improved accuracy.

Get the next $MOVE alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MOVE

Date	Price Target	Rating	Analyst

More analyst ratings

$MOVE
Financials

Live finance-specific insights

Movano Health Reports Q2 2024 Financial Results and Provides Business Update
Prepares for September 17, 2024, Evie Ring back in stock dateAnnounces brand partnership with digital creator Heidi D'AmelioFocuses on launch of EvieMED and securing B2B opportunitiesConference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., Aug. 14, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, reported second quarter 2024 results and provided a business update. Following the successful close of the Company's April 2024 $24.1 million private placement that included a seed investment from a tier 1 multi-billion dollar medical device
8/14/24 4:05:00 PM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Movano Health Provides Progress Update on EvieMED Regulatory Filing
Company continues to work with FDA to bring this pioneering healthcare product to market PLEASANTON, Calif., Aug. 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) plans to meet with the FDA in mid-August, as part of the Company's ongoing process to secure a 510(k) clearance for the EvieMED Ring, a wearable designed to not only provide medical device functionality through its pulse oximetry feature, but also offer numerous wellness metrics related to sleep, activity and mood/energy/symptom logging. On April 21, 2024, Movano Health filed an updated 510(k) for the EvieMED Ring's pulse oximetry feature. At the time of the filing and based on prior interactions with the agency and its protoco
8/5/24 9:00:00 AM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024
Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif., Aug. 5, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, today announced that it will report second quarter 2024 financial and operating results on Wednesday, August 14, 2024, after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at 2:00 pm PT/5:00 pm ET. Attendees can access the live webcast here or on the investors section of Movano Health's website at https://ir.movano.com. The c
8/5/24 9:00:00 AM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care

Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif., Nov. 4, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) (the "Company") provided an update on an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split. Based on its preliminary investigation, the Company believes that between the announcement of the reverse split on October 25, 2024, and its effective date on October 2
11/4/24 8:00:00 AM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED
Company remains optimistic on the potential for this pioneering healthcare solution PLEASANTON, Calif., Nov. 4, 2024 /PRNewswire/ -- Movano Health (NASDAQ: MOVE) announced today that it has submitted a complete response package to the FDA as part of the final phase of the Company's 510(k) application review of the EvieMED Ring. The Company remains optimistic on EvieMED's potential for 510(k) clearance. "Our team has worked diligently to provide a thorough response to the Agency's questions," said John Mastrototaro, President and CEO of Movano Health. "We look forward to the su
11/4/24 8:00:00 AM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
Company Communicating with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) (the "Company") announced today that it has opened an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split. "We are committed to transparency and protecting the interests of our Company and shareholders," said John Mastrototaro, President and CEO of Movano Health. "
10/31/24 8:30:00 AM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care

Movano Health Applies Advanced AI through Deep Learning To Deliver Improved Accuracy Of Heart Rate In Motion

Chat with this insight

Recent Analyst Ratings for
$MOVE

$MOVE
SEC Filings

Movano Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 424B5 filed by Movano Inc.

SEC Form S-8 filed by Movano Inc.

$MOVE
Market Insights

Live Market Insights

Shares of companies within the broader technology sector are trading higher amid overall market strength as investors assess this week's inflation data.

12 Information Technology Stocks Moving In Friday's Pre-Market Session